September 1, 2024Open Access

Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group

CGClaudia GianiUniversity of Milan RDRyan A. DenuThe University of Texas MD Anderson Cancer Center SLSilva LjevarFondazione IRCCS Istituto Nazionale dei Tumori

Key Points

Key points are not available for this paper at this time.

Abstract

In this series, the largest available, metastatic LGFMS, SEF, and H-LGFMS/SEF showed different courses. Systemic agents have modest efficacy, informing future trials of novel agents for these tumours.

KI fragen

Bookmark

View Full Paper

Cite This Study

Giani et al. (Sun,) studied this question.

synapsesocial.com/papers/69d72a12236f4746d4563bcc https://doi.org/https://doi.org/10.1016/j.esmoop.2024.103689

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper